secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fulgent Genetics, Inc. (FLGT)
CIK:        0001674930
Form:       8-K
Filed at:   2022-09-29T23:59:59+00:00
Accession:  0000950170-22-019049
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director John Bolger resigns from Fulgent Genetics board effective Sept 24, 2022
--------------------------------------------------------------------------------

- John Bolger resigned as director and Audit Committee Chair on Sept 24, 2022.
- He also left the Compensation and Nominating & Corporate Governance Committees.
- Resignation not due to any disagreement with company operations, policies, or practices.
- No replacement has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674930/000095017022019049/0000950170-22-019049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674930/000095017022019049/flgt-20220924.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-019049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer